WASHINGTON -- The Food and Drug Administration said Thursday that accumulating evidence suggests a Bayer AG drug used to prevent excessive bleeding during heart bypass surgery increases the risk of death when compared with other drugs.
WASHINGTON -- The Food and Drug Administration said Thursday that accumulating evidence suggests a Bayer AG drug used to prevent excessive bleeding during heart bypass surgery increases the risk of death when compared with other drugs.
